ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
Dow Jones
41.938,45
-1,63%
Euro vs US Dollar
1,02545
0,00%
Bitcoin
95.132,29
0,59%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) News

PSNL

Personalis (PSNL)

Personalis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DatumZeitQuelleÜberschriftSymbolFirma
11/01/202503h20Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PSNLPersonalis Inc
07/01/202522h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
07/01/202522h01Business WirePersonalis Reports Preliminary Fourth Quarter and Full Year 2024 RevenueNASDAQ:PSNLPersonalis Inc
27/12/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
27/12/202422h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PSNLPersonalis Inc
19/12/202415h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
19/12/202415h00Business WirePersonalis Advances Business Strategy with Investment from Merck and Extends Collaboration with ModernaNASDAQ:PSNLPersonalis Inc
18/12/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
18/12/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
16/12/202414h00Business WirePersonalis and Tempus Expand Collaboration to BiopharmaNASDAQ:PSNLPersonalis Inc
20/11/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
20/11/202422h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
20/11/202422h01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
06/11/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
06/11/202422h01Business WirePersonalis Reports Third Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
06/11/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
05/11/202422h01Business WirePersonalis to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
23/10/202422h01Business WirePersonalis to Announce Third Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
19/09/202423h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
16/09/202415h00Business WireESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD TestNASDAQ:PSNLPersonalis Inc
12/09/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
30/08/202422h43Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
22/08/202422h01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
20/08/202422h27Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:PSNLPersonalis Inc
20/08/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
19/08/202422h05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
16/08/202415h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
16/08/202414h30Business WirePersonalis and Tempus Announce Expanded CollaborationNASDAQ:PSNLPersonalis Inc
07/08/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
07/08/202422h01Business WirePersonalis Reports Second Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Kürzlich von Ihnen besucht

DBI
SDXP
SDAX
TG
TUI1
Tui
TG
NOV
Novo Nordisk
TG
ALV
Allianz
AMEX
XLV
Health Care Select Sector
CCOM
SILVER
SILVER
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
TG
RHM
Rheinmetall
NASDAQ
NVDA
NVIDIA
TG
D7G
Nel ASA
CCOM
US500
US 500
COIN
DOGEUSD
Dogecoin
COIN
AVAXUSD
Avalanche
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten